Top Markets
Coin of the day
CNS Pharmaceuticals, Inc. CNS Pharmaceuticals, Inc.

CNS Pharmaceuticals, Inc.

CNSP
Ранг среди акций #33273
CNS Pharmaceuticals, Inc. is a clinical-stage pharmaceutical firm primarily... CNS Pharmaceuticals, Inc. is a clinical-stage pharmaceutical firm primarily focused on developing innovative anti-cancer therapies for tumors affecting the brain and central nervous system. Its primary investigational compound, Berubicin, an anthracycline, is currently progressing through Phase I and II clinical trials as a potential treatment for glioblastoma multiforme, an aggressive form of brain cancer. To bolster its research and development initiatives, the company has entered into several strategic agreements. These include licensing arrangements with Houston Pharmaceuticals, Inc., The University of Texas M.D. Anderson Cancer Center, and Animal Life Sciences, LLC. Additionally, CNS Pharmaceuticals has a development agreement in place with WPD Pharmaceuticals Inc. and a collaborative partnership with Reata Pharmaceuticals, Inc. The company was founded in 2017 and is headquartered in Houston, Texas.
Цена акции
$5.47
Последняя синхронизация: 2026-08-14
Рыночная капитализация
$7.99M
Изменение (1 день)
6.21%
Изменение (1 год)
7.47%
Страна
US
Торговля CNS Pharmaceuticals, Inc. (CNSP)

Категория

История цены акций CNS Pharmaceuticals, Inc. (CNSP)
Наивысшая цена закрытия: $5.27 2026-08-01

Наименьшая цена закрытия: $3.79M 2019-11-01
История цены акций CNS Pharmaceuticals, Inc. с 2019 по 2026
Годовая динамика цены акций
Год Результативность
2026 (TTM) -16.52%
2025 -89.84%
2024 -99.87%
2023 -34.43%
2022 -90.86%
2021 -58.90%
2020 -43.49%
2019 0.00%
Цена акций похожих компаний или конкурентов
Компания Цена акций Изменение 1г% Страна
$505.24 28.63%
US
$846.09 29.41%
NL
$736.12 7.12%
CH
$1.07K -6.40%
KR
$255.38 13.33%
BE